The gall bladder cholecystokinin receptor exists in two guanine nucleotide-binding protein-regulated affinity states

Xavier Molero, Laurence J Miller

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

To study proximal events in cholecystokinin (CCK) action on bovine gall bladder smooth muscle, we used the hormone analogue D-Tyr-Gly-[(N1e28,31)CCK-26-32]-phenethyl ester (OPE), which has unique biological properties. This fully efficacious agonist differs from native CCK by not expressing supramaximal inhibition of cell shortening, yet it clearly interacts with the same receptor molecule. This was demonstrated in binding and affinity labeling studies, where both peptides label the same Mr 70,000-85,000 protein and both fully compete for binding of the other ligand. Further, its relatively high affinity for the low affinity CCK receptor permits the clear demonstration of two affinity states of a CCK receptor on a membrane preparation and makes possible evaluation of the molecular basis of these affinity states and their regulation. Analysis of homologous and heterologous binding curves performed with both CCK and OPE peptides and radioligands demonstrated the presence of two affinity states, with CCK being able to distinguish them (Kd1 = 0.48 ± 0.04 nM and Kd2 = 56.5 ± 7.4 nM) and OPE recognizing them equally (Kd1 = 0.94 ± 0.31 nM and Kd2 = 0.96 ± 0.23 nM). In the presence of nonhydrolyzable GTP analogues, there was a shift in distribution of receptors toward the low affinity state, with the total number of receptors and their absolute affinities for each peptide remaining constant. Thus, the gall bladder CCK receptor is a single molecule capable of assuming two interconvertible affinity states, regulated by a guanine nucleotide-binding protein. Two full agonists are capable of interacting with this molecule to yield different biological responses via different molecular events.

Original languageEnglish (US)
Pages (from-to)150-156
Number of pages7
JournalMolecular Pharmacology
Volume39
Issue number2
StatePublished - Feb 1991

Fingerprint

Cholecystokinin Receptors
Guanine Nucleotides
Cholecystokinin
Carrier Proteins
Urinary Bladder
Peptides
Guanosine Triphosphate
Smooth Muscle
Esters
Hormones
Ligands
Membranes
Proteins

ASJC Scopus subject areas

  • Pharmacology

Cite this

The gall bladder cholecystokinin receptor exists in two guanine nucleotide-binding protein-regulated affinity states. / Molero, Xavier; Miller, Laurence J.

In: Molecular Pharmacology, Vol. 39, No. 2, 02.1991, p. 150-156.

Research output: Contribution to journalArticle

@article{c905184f4cda499ba53cc2e80293f682,
title = "The gall bladder cholecystokinin receptor exists in two guanine nucleotide-binding protein-regulated affinity states",
abstract = "To study proximal events in cholecystokinin (CCK) action on bovine gall bladder smooth muscle, we used the hormone analogue D-Tyr-Gly-[(N1e28,31)CCK-26-32]-phenethyl ester (OPE), which has unique biological properties. This fully efficacious agonist differs from native CCK by not expressing supramaximal inhibition of cell shortening, yet it clearly interacts with the same receptor molecule. This was demonstrated in binding and affinity labeling studies, where both peptides label the same Mr 70,000-85,000 protein and both fully compete for binding of the other ligand. Further, its relatively high affinity for the low affinity CCK receptor permits the clear demonstration of two affinity states of a CCK receptor on a membrane preparation and makes possible evaluation of the molecular basis of these affinity states and their regulation. Analysis of homologous and heterologous binding curves performed with both CCK and OPE peptides and radioligands demonstrated the presence of two affinity states, with CCK being able to distinguish them (Kd1 = 0.48 ± 0.04 nM and Kd2 = 56.5 ± 7.4 nM) and OPE recognizing them equally (Kd1 = 0.94 ± 0.31 nM and Kd2 = 0.96 ± 0.23 nM). In the presence of nonhydrolyzable GTP analogues, there was a shift in distribution of receptors toward the low affinity state, with the total number of receptors and their absolute affinities for each peptide remaining constant. Thus, the gall bladder CCK receptor is a single molecule capable of assuming two interconvertible affinity states, regulated by a guanine nucleotide-binding protein. Two full agonists are capable of interacting with this molecule to yield different biological responses via different molecular events.",
author = "Xavier Molero and Miller, {Laurence J}",
year = "1991",
month = "2",
language = "English (US)",
volume = "39",
pages = "150--156",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

TY - JOUR

T1 - The gall bladder cholecystokinin receptor exists in two guanine nucleotide-binding protein-regulated affinity states

AU - Molero, Xavier

AU - Miller, Laurence J

PY - 1991/2

Y1 - 1991/2

N2 - To study proximal events in cholecystokinin (CCK) action on bovine gall bladder smooth muscle, we used the hormone analogue D-Tyr-Gly-[(N1e28,31)CCK-26-32]-phenethyl ester (OPE), which has unique biological properties. This fully efficacious agonist differs from native CCK by not expressing supramaximal inhibition of cell shortening, yet it clearly interacts with the same receptor molecule. This was demonstrated in binding and affinity labeling studies, where both peptides label the same Mr 70,000-85,000 protein and both fully compete for binding of the other ligand. Further, its relatively high affinity for the low affinity CCK receptor permits the clear demonstration of two affinity states of a CCK receptor on a membrane preparation and makes possible evaluation of the molecular basis of these affinity states and their regulation. Analysis of homologous and heterologous binding curves performed with both CCK and OPE peptides and radioligands demonstrated the presence of two affinity states, with CCK being able to distinguish them (Kd1 = 0.48 ± 0.04 nM and Kd2 = 56.5 ± 7.4 nM) and OPE recognizing them equally (Kd1 = 0.94 ± 0.31 nM and Kd2 = 0.96 ± 0.23 nM). In the presence of nonhydrolyzable GTP analogues, there was a shift in distribution of receptors toward the low affinity state, with the total number of receptors and their absolute affinities for each peptide remaining constant. Thus, the gall bladder CCK receptor is a single molecule capable of assuming two interconvertible affinity states, regulated by a guanine nucleotide-binding protein. Two full agonists are capable of interacting with this molecule to yield different biological responses via different molecular events.

AB - To study proximal events in cholecystokinin (CCK) action on bovine gall bladder smooth muscle, we used the hormone analogue D-Tyr-Gly-[(N1e28,31)CCK-26-32]-phenethyl ester (OPE), which has unique biological properties. This fully efficacious agonist differs from native CCK by not expressing supramaximal inhibition of cell shortening, yet it clearly interacts with the same receptor molecule. This was demonstrated in binding and affinity labeling studies, where both peptides label the same Mr 70,000-85,000 protein and both fully compete for binding of the other ligand. Further, its relatively high affinity for the low affinity CCK receptor permits the clear demonstration of two affinity states of a CCK receptor on a membrane preparation and makes possible evaluation of the molecular basis of these affinity states and their regulation. Analysis of homologous and heterologous binding curves performed with both CCK and OPE peptides and radioligands demonstrated the presence of two affinity states, with CCK being able to distinguish them (Kd1 = 0.48 ± 0.04 nM and Kd2 = 56.5 ± 7.4 nM) and OPE recognizing them equally (Kd1 = 0.94 ± 0.31 nM and Kd2 = 0.96 ± 0.23 nM). In the presence of nonhydrolyzable GTP analogues, there was a shift in distribution of receptors toward the low affinity state, with the total number of receptors and their absolute affinities for each peptide remaining constant. Thus, the gall bladder CCK receptor is a single molecule capable of assuming two interconvertible affinity states, regulated by a guanine nucleotide-binding protein. Two full agonists are capable of interacting with this molecule to yield different biological responses via different molecular events.

UR - http://www.scopus.com/inward/record.url?scp=0026063530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026063530&partnerID=8YFLogxK

M3 - Article

C2 - 1899903

AN - SCOPUS:0026063530

VL - 39

SP - 150

EP - 156

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 2

ER -